Combined platelet count with sCD163 and genetic variants optimizes esophageal varices prediction in cirrhotic patients
Journal of Gastroenterology and Hepatology, 08/20/2012
Yang YY et al. – The study suggested that high sCD163 levels and genetic risk variants are additional markers that can be combined with low platelet count to optimize assessment of EVs and bleeding in cirrhotic patients.



